Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 60 2013 074 552.8 |
96 | EP file number | EAKZ | 18 16 2971.8 |
97 | EP publication number | EPN | 3400943 |
54 | Designation/title | TI | VERBINDUNGEN ZUR VERWENDUNG BEI DER BEHANDLUNG VON HIRNMETASTASEN BEI EINEM PATIENTEN MIT ERBB2+ BRUSTKREBS |
51 | IPC main class | ICM (ICMV) | A61K 31/517 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 45/06 (2006.01), A61K 31/337 (2006.01), A61K 31/7068 (2006.01), A61K 39/395 (2006.01), A61P 35/04 (2006.01), A61P 35/00 (2006.01) |
22 | DE application date | DAT | Mar 25, 2013 |
96 | EP application date | EAT | Mar 25, 2013 |
43 | Date of first publication | OT | Nov 14, 2018 |
| Date of publication of grant | PET | Dec 2, 2020 |
71/73 | Applicant/owner | INH | Array Biopharma, Inc., Boulder, Col., US |
72 | Inventor | IN | LEE, Patrice A., Boulder, CO 80301, US; WINSKI, Shannon L., Boulder, CO 80301, US; KOCH, Kevin, Boulder, CO 80301, US |
74 | Representative | VTR | Office Freylinger S.A., Strassen, LU |
| Address for service | | OFFICE FREYLINGER S.A., 8001 STRASSEN, LU |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201261615082 P Mar 23, 2012
|
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000003400943A1 Searchable text:
EP000003400943A1 Original document:
EP000003400943B1 Searchable text:
EP000003400943B1 |
43 | Date of first publication | EVT | Nov 14, 2018 |
| Date of the first transfer into DPMAregister | EREGT | Nov 14, 2018 |
| Date of the (most recent) update in DPMAregister | REGT | Apr 3, 2025 (Show all update days)(Hide all update days)- Apr 3, 2025
- Procedures: Opposition procedure, Decision on revocation by EPO has become final, 10.01.2025: changed
- Feb 27, 2025
- Status: changed
- Due date: deleted
- Procedures: Opposition procedure, Revocation by EPO, 10.01.2025: new
- Procedures: Opposition procedure, Decision on revocation by EPO has become final, 10.01.2025: new
- Feb 14, 2025
- Sep 26, 2024
- St.36: changed (technical change)
- May 16, 2024; Feb 15, 2024; Feb 16, 2023; Feb 15, 2022; Oct 21, 2021; Sep 23, 2021; Mar 23, 2021; Jan 15, 2021; Dec 17, 2020; Nov 13, 2020; Nov 12, 2020; Jul 2, 2020; Jun 11, 2020; Aug 15, 2019; May 30, 2019
- Historical data not available for this/these date(s)
- Nov 14, 2018
- Date of the first transfer into DPMAregister
|